Singapore's out and China's in for Eli Lilly and Co.'s effort to grow sales internationally.After recently deciding to close a research center in Singapore, the Indianapolis-based drugmaker has decided to open a diabetes research center in China in the second half of 2011, further ramping up its presence in what is now the world’s second-largest economy. Full story
